Associated partners
Goethe University Frankfurt
Associated partners of the DZIF are researchers based at German universities and research institutions that are not among the DZIF’s member institutions. Partners at Goethe University Frankfurt are (as of March 31, 2026):
Jörg Janne Vehreschild, Maria Vehreschild, and Sandra Ciesek.
The Goethe University Frankfurt is active in the DZIF research areas Hepatitis and Healthcare-Associated Infections.
In the Hepatitis research area, a collaborative project is taking place, among others, to optimise the treatment of hepatitis C patients with novel agents—so-called Directly Acting Antivirals (DAA)—and to develop a prophylactic vaccine. The Goethe University is also involved in a DZIF study on the treatment of hepatitis E.